Photo from wikipedia
The only curative treatment for end-stage liver disease is liver transplantation. However, a shortage of donor organs, financial burden on the patients, and the need for lifelong immunosuppression are major… Click to show full abstract
The only curative treatment for end-stage liver disease is liver transplantation. However, a shortage of donor organs, financial burden on the patients, and the need for lifelong immunosuppression are major limitations. One potential solution to these issues would be to bioengineer a functioning liver from a patient's own cells in the lab, and transplant the lab-grown organ into the patient. This technology could theoretically provide unlimited grafts without the need for immunosuppression.
Keywords:
bioengineered mini;
livers transplantation;
human livers;
transplantation;
mini human;
hepatology
Journal Title: Hepatology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Hepatology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!